Im studying nanomaterials but my application is not in the area of cancer. Can I still submit a proposal for characterization by the NCL?
A. The NCL serves as a national resource and knowledge base for researchers to facilitate the regulatory review of nanotechnologies intended for cancer therapies and diagnostics. The NCL generally does not accept proposals for characterization of nanomaterials intended for application in areas other than cancer . Cancer-related nanostrategies proposed to the NCL for characterization are ranked according to their projected impact on clinical cancer applications and/or furthering nanotechnologys compatibility with biological systems. Specific evaluation criteria include, but are not limited to: Previously demonstrated efficacy in vitro and/or in animal models Advantages offered by the strategy over existing cancer therapies or diagnostics Previous physical characterization of the nanomaterial such as purity and stability The nanostrategys manufacturing process and compatibility with scale-up The materials inherent toxicity and/or environmental concerns Plans or approach to transition the
